< Back to Research Centers

About This Center

Virginia Commonwealth University’s Lewy Body Dementia Association Research Center of Excellence is based within the VCU Parkinson’s and Movement Disorders Center, a nationally recognized program providing specialized care and conducting research in Lewy body dementia, Parkinson’s disease, and related neurological disorders.

Drs. Matthew Barrett and Trey Bateman provide specialized care for patients with Lewy body dementia and related disorders through the Alzheimer’s and Cognitive Disorders Clinic. A full-time nurse practitioner provides follow-up care for patients with dementia. Patients receive care from a multidisciplinary team that includes movement disorders neurologists, behavioral neurologists, nurse practitioners, nurse navigators, and neuropsychologists. The team works closely with physical therapists, occupational therapists, and speech-language pathologists to address the cognitive, movement, behavioral, and functional symptoms that can occur with Lewy body dementia.

Clinical services are provided at VCU Health locations in Richmond, including Short Pump Pavilion and the Adult Outpatient Pavilion in downtown Richmond. These locations offer access to comprehensive neurological services and coordinated, patient-centered care. The center supports patients and families beyond the clinic through an LBDA-affiliated caregiver support group. The group provides education, practical resources, and opportunities for caregivers to connect with others who understand the challenges of caring for someone with Lewy body dementia.

Research is a central part of the VCU Research Center of Excellence. The Parkinson’s and Movement Disorders Center maintains a dedicated research infrastructure that is currently expanding through the recruitment of additional personnel. Dr. Barrett is the principal investigator of an NIH-funded study examining the mechanisms of cognitive fluctuations in Lewy body dementia. The center also participates in multicenter clinical trials and collaborative clinical research focused on improving the diagnosis, monitoring, and treatment of Lewy body dementia and related conditions.

Locations

Contact Information

Name: Kara McHaney
Email: [email protected]
Phone: 804-828-4788
Contact for: Clinical Trials

Contact Name: Brittany Gibson
Email Address: [email protected]
Phone Number: 804-360-4669
Contact this person for: Clinic Appointments

Website: VCU Parkinson's and Movement Disorders Center

Dr. Matthew Barrett

Dr. Matthew Barrett, Principal Investigator, is a Professor of Neurology at Virginia Commonwealth University (VCU) in Richmond, VA. He specializes in the care of patients with movement disorders and dementia, with a particular focus on conditions that overlap these areas, including Parkinson’s disease, Dementia with Lewy bodies (DLB), and Progressive Supranuclear Palsy (PSP). His research is dedicated to improving the treatment of cognitive impairment in Parkinson’s disease and DLB by advancing the understanding of their underlying mechanisms. His work aims to refine diagnostic tools, identify biomarkers, and develop targeted therapeutic strategies for patients with cognitive dysfunction in movement disorders. He joined the faculty at VCU in 2019. In addition to his role as principal investigator of the LBDA RCOE at VCU, he is director of the CurePSP Center of Care and program director of the movement disorders fellowship.

Dr. Matthew Barrett photo
The Virginia Commonwealth University (VCU) logo
Loading map...

Learn about LBD

Educational resources to assist individuals with LBD, their families and healthcare providers.

Program thumbnail

Lewy Trial Tracker

You can accelerate research by participating in clinical studies. Sign up for the Lewy Trial Tracker today.

Program thumbnail

Research Centers

Through its Research Centers of Excellence, LBDA partners with 27 leading institutions to provide advanced care and connect the LBD community with specialized, research‑driven expertise.

Program thumbnail

Advisory Council

The LBDA Advisory Council (AC) convenes leaders in the LBD academic medical/scientific community, federal agencies and biotech companies with the aim of advancing the study of LBD diagnostic tools and treatments.